It would only be wrong if SIRG were not in the OTCs. While in a reputable blue chip stock, the O/S is used for valuations, in this market smart investors use the A/S since dilution is assumed. Since SIRG has no revenue and a history of convertible toxic debt notes (that they haven't been paying), that methodology definitely holds true here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.